Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Insights From a Mixed Methods Analysis of 3 Health Technologies Used in Patients With Parkinson Disease: Mixed Methods Study

D. Pérez-Rangel, MHG. Monje, S. Grosjean, M. Srp, L. Antunes, R. Bouça-Machado, R. Cacho, S. Domínguez Rodríguez, J. Inocentes, T. Lynch, A. Tsakanika, D. Fotiadis, G. Rigas, E. Růžička, JJ. Ferreira, A. Antonini, N. Malpica, T. Mestre, Á....

. 2025 ; 27 (-) : e67986. [pub] 20250801

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25022116

BACKGROUND: The transition to a patient-centered integrated care model in Parkinson disease (PD) highlights the crucial role of technology. "Technology-enabled care" (TEC) supports diagnosis, disease tracking, self-care education, and care team communication. However, gaps remain in developing and evaluating patient-centered TEC solutions. OBJECTIVE: This study aims to evaluate the usability and acceptability of 3 health technologies for PD and discuss the significance of the results. METHODS: This multicenter international study was conducted from December 2020 to September 2023 across 5 tertiary PD centers. Participants included individuals diagnosed with PD who were recruited through these centers. Each participant provided informed consent before enrollment. The study assessed the usability and acceptability of 3 different health technologies designed to support PD management. The System Usability Scale (SUS) was used as the primary quantitative measure, with scores ranging from 0 to 100, with higher scores indicating greater usability. Additionally, participants completed a custom usability and acceptability survey, which included Likert-scale questions and open-ended qualitative feedback. To ensure a comprehensive evaluation, structured user testing sessions were conducted. Participants interacted with each technology under guided conditions, followed by independent use in their home environment for a specified period. Data were collected at baseline and after the trial period to assess any changes in user perception. Qualitative thematic analysis of free-text responses was performed to identify key themes related to user experience, perceived benefits, and challenges. Two independent researchers analyzed the qualitative data to ensure reliability and consistency in theme extraction. RESULTS: The study included 43 people with PD, of whom 15 were female. The median age of participants was 67.0 (IQR 59.9-71.5) years, and the median disease duration was 9.6 (IQR 5.0-13.7) years. The 3 health technologies demonstrated acceptable usability, with median SUS scores ranging from 74.0 to 82.5. Participants expressed a generally positive attitude toward TEC, with a strong interest in continued use. Users particularly valued confidence in navigating the technology and its role in facilitating disease management. The qualitative analysis highlighted several challenges. Users frequently mentioned the need for improved technical support, clearer instructional materials, and simplified report formats to enhance interpretability. Some participants experienced difficulties with initial setup and required assistance, emphasizing the importance of user-friendly onboarding processes. CONCLUSIONS: Our study underscores the importance of incorporating patient perspectives in the development of health technologies for PD. Positive user experiences demonstrate the potential of TEC to enhance disease management, but addressing usability challenges remains critical. Future efforts should focus on refining user interfaces, providing comprehensive technical support, and ensuring clear, accessible instructions to maximize adoption and long-term engagement. By prioritizing these aspects, TEC can play a pivotal role in advancing patient-centered health care solutions for PD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25022116
003      
CZ-PrNML
005      
20251023080047.0
007      
ta
008      
251014e20250801xxc f 000 0|eng||
009      
AR
024    7_
$a 10.2196/67986 $2 doi
035    __
$a (PubMed)40749223
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Pérez-Rangel, Daniel $u Movement Disorders Unit, Neurology Department, Hospital Universitario 12 De Octubre, Av. de Córdoba, s/n, Usera, Madrid, 28041, Spain, 34 913908000 $1 https://orcid.org/0009000796274602
245    10
$a Insights From a Mixed Methods Analysis of 3 Health Technologies Used in Patients With Parkinson Disease: Mixed Methods Study / $c D. Pérez-Rangel, MHG. Monje, S. Grosjean, M. Srp, L. Antunes, R. Bouça-Machado, R. Cacho, S. Domínguez Rodríguez, J. Inocentes, T. Lynch, A. Tsakanika, D. Fotiadis, G. Rigas, E. Růžička, JJ. Ferreira, A. Antonini, N. Malpica, T. Mestre, Á. Sánchez-Ferro, iCARE-PD Consortium
520    9_
$a BACKGROUND: The transition to a patient-centered integrated care model in Parkinson disease (PD) highlights the crucial role of technology. "Technology-enabled care" (TEC) supports diagnosis, disease tracking, self-care education, and care team communication. However, gaps remain in developing and evaluating patient-centered TEC solutions. OBJECTIVE: This study aims to evaluate the usability and acceptability of 3 health technologies for PD and discuss the significance of the results. METHODS: This multicenter international study was conducted from December 2020 to September 2023 across 5 tertiary PD centers. Participants included individuals diagnosed with PD who were recruited through these centers. Each participant provided informed consent before enrollment. The study assessed the usability and acceptability of 3 different health technologies designed to support PD management. The System Usability Scale (SUS) was used as the primary quantitative measure, with scores ranging from 0 to 100, with higher scores indicating greater usability. Additionally, participants completed a custom usability and acceptability survey, which included Likert-scale questions and open-ended qualitative feedback. To ensure a comprehensive evaluation, structured user testing sessions were conducted. Participants interacted with each technology under guided conditions, followed by independent use in their home environment for a specified period. Data were collected at baseline and after the trial period to assess any changes in user perception. Qualitative thematic analysis of free-text responses was performed to identify key themes related to user experience, perceived benefits, and challenges. Two independent researchers analyzed the qualitative data to ensure reliability and consistency in theme extraction. RESULTS: The study included 43 people with PD, of whom 15 were female. The median age of participants was 67.0 (IQR 59.9-71.5) years, and the median disease duration was 9.6 (IQR 5.0-13.7) years. The 3 health technologies demonstrated acceptable usability, with median SUS scores ranging from 74.0 to 82.5. Participants expressed a generally positive attitude toward TEC, with a strong interest in continued use. Users particularly valued confidence in navigating the technology and its role in facilitating disease management. The qualitative analysis highlighted several challenges. Users frequently mentioned the need for improved technical support, clearer instructional materials, and simplified report formats to enhance interpretability. Some participants experienced difficulties with initial setup and required assistance, emphasizing the importance of user-friendly onboarding processes. CONCLUSIONS: Our study underscores the importance of incorporating patient perspectives in the development of health technologies for PD. Positive user experiences demonstrate the potential of TEC to enhance disease management, but addressing usability challenges remains critical. Future efforts should focus on refining user interfaces, providing comprehensive technical support, and ensuring clear, accessible instructions to maximize adoption and long-term engagement. By prioritizing these aspects, TEC can play a pivotal role in advancing patient-centered health care solutions for PD.
650    _2
$a lidé $7 D006801
650    12
$a Parkinsonova nemoc $x terapie $x diagnóza $7 D010300
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a senioři $7 D000368
650    _2
$a lidé středního věku $7 D008875
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a telemedicína $7 D017216
650    12
$a biomedicínské technologie $7 D020811
650    _2
$a péče o sebe $7 D012648
650    _2
$a péče orientovaná na pacienta $7 D018802
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Monje, Mariana H G $u Ken and Ruth Davee Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States $1 https://orcid.org/0000000207304061
700    1_
$a Grosjean, Sylvie $u Department of Communication, Com&Tech Innovations Lab, University of Ottawa, Ottawa, ON, Canada $1 https://orcid.org/0000000245680500
700    1_
$a Srp, Martin $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000322150272
700    1_
$a Antunes, Laura $u CNS - Campus Neurológico Torres Vedras, Lisbon, Portugal $1 https://orcid.org/0009000718870652
700    1_
$a Bouça-Machado, Raquel $u CNS - Campus Neurológico Torres Vedras, Lisbon, Portugal $1 https://orcid.org/0000000337562763
700    1_
$a Cacho, Ricardo $u CNS - Campus Neurológico Torres Vedras, Lisbon, Portugal $1 https://orcid.org/0009000836842468
700    1_
$a Domínguez Rodríguez, Sergio $u LAIMBIO, Laboratorio de Análisis de Imagen Médica y Biometría, Universidad Rey Juan Carlos, Madrid, Spain $1 https://orcid.org/0009000677368585
700    1_
$a Inocentes, John $u Dublin Neurological Institute, Mater Misericordiae University Hospital, Dublin, Ireland $1 https://orcid.org/0000000160864829
700    1_
$a Lynch, Timothy $u Dublin Neurological Institute, Mater Misericordiae University Hospital, Dublin, Ireland $1 https://orcid.org/0000000223808737
700    1_
$a Tsakanika, Argyri $u PD Neurotechnology, Athens, Greece $1 https://orcid.org/0009000121399300
700    1_
$a Fotiadis, Dimitrios $u PD Neurotechnology, Athens, Greece $1 https://orcid.org/0000000273625082
700    1_
$a Rigas, George $u PD Neurotechnology, Athens, Greece $1 https://orcid.org/0000000251026185
700    1_
$a Růžička, Evžen $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000248939661 $7 jo20000074065
700    1_
$a Ferreira, Joaquim J $u CNS - Campus Neurológico Torres Vedras, Lisbon, Portugal $1 https://orcid.org/0000000339505113
700    1_
$a Antonini, Angelo $u Parkinson and Movement Disorders Unit, Department of Neurosciences, Padova University, Padova, Italy $1 https://orcid.org/0000000310402807
700    1_
$a Malpica, Norberto $u LAIMBIO, Laboratorio de Análisis de Imagen Médica y Biometría, Universidad Rey Juan Carlos, Madrid, Spain $1 https://orcid.org/0000000346187459
700    1_
$a Mestre, Tiago $u Parkinson's Disease and Movement Disorders Center, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa's Brain and Mind Research Institute, Ottawa, ON, Canada $1 https://orcid.org/0000000269737479
700    1_
$a Sánchez-Ferro, Álvaro $u Movement Disorders Unit, Neurology Department, Hospital Universitario 12 De Octubre, Av. de Córdoba, s/n, Usera, Madrid, 28041, Spain, 34 913908000 $1 https://orcid.org/0000000324612485
710    2_
$a iCARE-PD Consortium
773    0_
$w MED00007388 $t JMIR. Journal of medical internet research $x 1438-8871 $g Roč. 27 (20250801), s. e67986
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40749223 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251014 $b ABA008
991    __
$a 20251023080052 $b ABA008
999    __
$a ok $b bmc $g 2417102 $s 1260279
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 27 $c - $d e67986 $e 20250801 $i 1438-8871 $m JMIR. Journal of medical internet research $n J Med Internet Res $x MED00007388
LZP    __
$a Pubmed-20251014

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace